| Literature DB >> 29516003 |
Sara Ahmed1, Dhanveer Singh2, Shereen Khattab1, Jessica Babineau3, Dinesh Kumbhare4.
Abstract
BACKGROUND: There is an increasing trend in the consumption of poor-quality diets worldwide, contributing to the increase of non-communicable diseases. Diet directly influences physiological composition and subsequently physical health. Studies have shown that dietary macronutrient and energy content can influence the proportion of intramuscular fat (IMF), which mediates various metabolic and endocrine dysfunction. The purpose of this systematic review was to identify evidence in the literature assessing the association between different dietary interventions on the proportion of IMF in humans.Entities:
Keywords: diet; energy; high-fat diets; intramuscular fat; review
Year: 2018 PMID: 29516003 PMCID: PMC5826234 DOI: 10.3389/fnut.2018.00007
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analysis flow diagram.
Quality assessment of articles.
| Hypothesis/aim/objective clearly described? | Main outcomes clearly described in the Introduction/Methods? | Characteristics of patients clearly described? | Interventions of interest clearly described? | Distribution of principal confounders in each group of subjects to be compared clearly described? | Main findings of the study clearly described? | Does the study provide estimates of random variability in the data for main outcomes? | Have all important adverse events that may be a consequence of intervention been reported? | Have the characteristics of patients lost to follow-up been described? | Have actual probability values been reported for main outcomes except where probability is <0.001? | Were the subjects asked to participate in the study representative of the entire population from which they were recruited? | Were those subjects who were prepared to participate representative of the entire population from which they were recruited? | Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? | Was an attempted made to blind study subjects to the intervention they received? | Was an attempt made to blind those measuring the main outcomes of the intervention? | If any results of were based on “data dragging,” was it made clear? | In trials/cohort studies, do the analyses adjust for different lengths of follow-up, or in case–control studies, is the time period between intervention and outcome the same for cases and controls? | Were the statistical tests used to assess main outcomes appropriate? | Was compliance with the intervention(s) reliable? | Were the main outcome measures used accurate (valid and reliable)? | Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited from the same population? | Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited over the same period of time? | Were study subjects randomized to intervention groups? | Was the randomized intervention assignment concealed from both patients/staff until recruitment was complete and irrevocable? | Was the adequate adjustment for confounding in the analyses from which the main findings were drawn? | Were losses of patients to follow-up taken into account? | Did the study have sufficient power to detect clinically important effect where | Total score (31) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | N | N | N | Y | N | Y | Y | Y | Y | Y | Y | Y | N | N | Y | Y | 4 | 23 |
| ( | Y | Y | Y | Y | N | Y | Y | N | Y | N | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y | N | N | Y | Y | 5 | 25 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | N | N | N | Y | N | N | Y | Y | Y | N | Y | Y | Y | N | N | Y | Y | 3 | 20 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | N | N | N | Y | N | N | Y | Y | Y | Y | Y | Y | N | Y | Y | N | Y | 5 | 23 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | N | N | Y | N | N | Y | Y | Y | N | Y | N | N | Y | N | Y | N | 5 | 21 |
| ( | Y | Y | Y | Y | N | Y | Y | N | Y | Y | N | N | Y | N | N | Y | Y | Y | Y | Y | N | N | Y | N | N | N | 5 | 20 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | N | N | N | Y | Y | Y | N | Y | Y | Y | Y | N | N | Y | Y | N | N | 5 | 22 |
| ( | Y | Y | Y | Y | N | Y | Y | N | N | N | N | N | Y | N | N | Y | Y | Y | Y | Y | Y | N | N | N | N | N | 5 | 19 |
| ( | Y | Y | Y | Y | N | Y | Y | N | Y | Y | N | N | N | N | N | Y | Y | Y | Y | Y | N | N | N | N | Y | Y | 5 | 20 |
| ( | Y | Y | Y | Y | N | Y | Y | N | Y | Y | N | N | N | N | N | Y | Y | Y | Y | Y | Y | N | N | N | N | Y | 5 | 20 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | Y | N | N | Y | N | N | Y | 3 | 21 |
| ( | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | 5 | 28 |
| ( | Y | Y | Y | Y | Y | Y | Y | N | Y | N | N | N | Y | N | N | Y | Y | Y | Y | Y | N | N | Y | N | N | Y | 5 | 21 |
Summary of findings.
| Author | Sample size (N) | Age | Study design | Sample characteristics | Intervention | Assessment site | Assessment method | Postintervention/IMF proportion |
|---|---|---|---|---|---|---|---|---|
| Larson-Meyer et al. ( | M = 20, F = 26 ( | 25–50 | Randomized controlled trial | Healthy, sedentary overweight men and women | 1. Control (C) | Soleus muscle | H1 magnetic resonance spectroscopy | No difference 25% calorie restriction and C/no difference between low calorie and C |
| 2. 25% calorie restriction of baseline energy requirements | ||||||||
| 3. Low-calorie diet until 15% reduction in weight | ||||||||
| Johnson et al. ( | M = 7 ( | 30 (6) | Randomized crossover design | Healthy, physically fit males | 1. Control: mixed carbohydrate diet (C) | Vastus lateralis | H1 magnetic resonance spectroscopy | HF > C, S > C/no difference HF and S |
| 2. Water-only starvation (S) | ||||||||
| 3. Low-carbohydrate/high-fat intake (HF) | ||||||||
| Green et al. ( | M = 66 ( | 38.8 (12.7) | Randomized crossover design | Healthy, physically fit men | 1. Control: mixed diet (C) | Vastus lateralis | H1 magnetic resonance spectroscopy | S > C, S > HP/no difference HP and C |
| 2. Water-only starvation (S) | ||||||||
| 3. Low-carbohydrate/high-protein intake (HP) | ||||||||
| Johnson et al. ( | M = 6 ( | 32 (2.2) | Randomized crossover design | Healthy, physically fit males | 1. Control: high-carbohydrate diet (C) | Vastus lateralis | H1 magnetic resonance spectroscopy | HF > C |
| 2. Low-carbohydrate/high-fat diet (HF) | ||||||||
| St-Onge et al.. ( | ( | 44 (2.5) | Randomized crossover design | Healthy men and women with mildly elevated LDL | 1. Control: low-fat diet (C) | Soleus | H1 magnetic resonance spectroscopy | HF > C |
| 2. High-fat diet (HF) | ||||||||
| Kiens et al. ( | M = 19 ( | 36 (30–40) | Controlled trial | Healthy, physically active males | 1. Control diet (C) | Vastus lateralis | Biopsy and chemical extraction | HF > C/no difference HC and C |
| 2. High-fat diet (HF) | ||||||||
| 3. High-carbohydrate diet (HC) | ||||||||
| Sakurai et al. ( | M = 37 ( | 23.6 (0.5) | Randomized crossover design | Healthy, non-obese male volunteers | 1. Control: normal fat diet (C) | Soleus and tibialis anterior | H1 magnetic resonance spectroscopy | i. HF > C, ii. HF > C |
| 2. High-fat diet (HF) | ||||||||
| Schrauwen-Hinderling ( | M = 10 ( | 25 (6.2) | Randomized crossover design | Healthy, young male subjects | 1. Control: normal fat diet (C) | Vastus lateralis | H1 magnetic resonance imaging | No difference |
| 2. High-fat diet (HF) | ||||||||
| Skovbro et al. ( | M = 21 ( | 23.7 (2.74) | Randomized controlled trial | Healthy, untrained male subjects | 1. Control: normal fat diet (C) | Vastus lateralis | Biopsy and spectrophotometry | No differences |
| 2. High-fat diet (HF) | ||||||||
| Sock et al. ( | M = 11 ( | 25 (0.6) | Randomized crossover design | Healthy, non-smoking males | 1. Control diet (C) | Not specified | H1 magnetic resonance spectroscopy | HGlu > C/no difference HFru and C |
| 2. High-glucose diet (HGlu) | ||||||||
| 3. High-fructose diet (HFlu) | ||||||||
| Larson-Meyer et al. ( | ( | 18–45 | Randomized crossover design | Healthy, endurance trained runners | 1. Control: moderate fat diet (C) | Vastus lateralis | Biopsy and transmission electron microscopy | HC < C |
| 2. High-carbohydrate diet (HC) | ||||||||
| van Herpen et al. ( | ( | 55.2 (7.6) | Randomized controlled trial | Healthy, sedentary men | 1. Control: low-fat diet (C) | Vastus lateralis | Biopsy and Oil Red stain | No difference between change C change vs. HF change |
| 2. High-fat diet (HF) | ||||||||
| Maersk et al. ( | M = 17, F = 30 ( | 20–50 | Randomized controlled trial | Healthy, overweight, non-diabetic subjects | 1. Control: water (C) | Tibialis anterior | H1 magnetic resonance spectroscopy | Sucrose/fructose difference > control/no difference milk and control |
| 2. 1 L of sucrose and fructose | ||||||||
| 3. Semi-skim milk | ||||||||
.
Figure 2Meta-analysis on the effects of high-fat diets on IMTG proportions.
Subgroup and sensitivity analysis.
| Analysis | SMD (95% CI) | Significance |
|---|---|---|
| Primary analysis | 1.24 (0.43, 2.05) | 0.003 |
| Sensitivity analysis: excluding studies with a quality value <20, smallest sample size <8, and those that do not specify participant characteristics | 1.26 (0.23, 2.28) | 0.02 |
| Male only studies | 1.4 (0.55, 2.25) | 0.05 |
| Mixed studies (21% M, 79% F) | 0.38 (−0.20, 0.96) | |
| Controlled trial | 0.58 (−0.30, 1.46) | 0.23 |
| Controlled crossover trial | 1.35 (0.44, 2.25) | |
| H1MRS | 1.55 (0.57, 2.54) | 0.06 |
| Biopsy | 0.44 (−0.18, 1.05) | |
| Vastus lateralis | 0.70 (0.17, 1.22) | Reference group |
| Soleus | 1.35 (−0.55, 3.26) | 0.52 |
| Tibialis anterior | 2.58 (1.96, 3.20) | <0.001 |
| Active | 1.09 (−0.09, 2.27) | 0.26 |
| Inactive | 0.36 (−0.12, 0.84) | |
Subgroup analyses (Der Simonian and Laird) random-effects model.
CI, confidence interval; SMD, standardized mean difference.
*Significance defined as P < 0.05.